Virios Therapeutics, Inc.·4

May 24, 2:53 PM ET

Walsh Angela 4

4 · Virios Therapeutics, Inc. · Filed May 24, 2022

Insider Transaction Report

Form 4
Period: 2022-05-23
Walsh Angela
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2022-05-23$4.58/sh+2,000$9,1503,000 total(indirect: By IRA)

Documents

1 file
  • 4
    form4-05242022_110533.xmlPrimary